Simon Cottle

Founding Partner @ Stanley Capital | Private Equity, MBA

📍 London, England Metropolitan Area, United Kingdom🔄 Updated September 2026💼 16 investments📅 15 years investing🗓 Last invested Sep 2025
VC🌍 United KingdomInvested this year
16
Total investments
3
Early stage
2
Mid stage
2
Late stage
15y
Years active

Portfolio

11 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Sep 2025
Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale. Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.
Investor
Jul 2025
AI agents that actually work in your business. While others struggle to get agents into production, Beam AI delivers reliable automation for Fortune 500 companies and scale-ups. Automate finance, HR, and operations workflows that reduce operational costs and scale your teams impact.
Investor
Mar 2025
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artificial intelligence benefits all of humanity. AI is an extremely powerful tool that must be created with safety and human needs at its core. OpenAI is dedicated to putting that alignment of interests first — ahead of profit. To achieve our mission, we must encompass and value the many different perspectives, voices, and experiences that form the full spectrum of humanity. Our investment in diversity, equity, and inclusion is ongoing, executed through a wide range of initiatives, and championed and supported by leadership. At OpenAI, we believe artificial intelligence has the potential to help people solve immense global challenges, and we want the upside of AI to be widely shared. Join us in shaping the future of technology.
Investor and Board observer
Dec 2022
At Arietta.ai, we empower our customers to achieve brilliant innovation. We are committed to delivering responsible AI-powered solutions that accelerate quality medical decision-making and data insights. Our passion lies in merging cutting-edge artificial intelligence (AI) technologies with a profound understanding of healthcare, driving us to create a healthier world through the convergence of data, innovation, and insight.
Investor
Sep 2022
Founded in 2015, LXO Group is a pharmaceutical company operating a range of products generating annual sales of over 90 million euros and covering more than 80 countries. We are committed to meeting the needs of healthcare professionals and patients for our medicines, medical devices and cosmetics. Our growth is fuelled by the success of our brands, our international expansion and our strategy of external acquisitions. We are supported by a strong workforce, our own sales force and a network of partners and sales representatives who are ready to invest in the development of our products.
Board Observer and Investor
Sep 2022
We are practitioners with centuries of combined expertise in enhancing organizations with innovative, human-centric solutions that create substantial and sustainable value by improving efficiency and profitability through intelligent technologies. We stand out because of our unique way of doing things.   Our Holistic Approach: We use smart technology to improve your current systems, processes, and people so that everything runs smoother.   People-Centric: We dont just focus on tech; we blend our expertise with empathy. We care about your long-term success and ensure you get real value from our services.  Trusted Partners: Were not your typical consultants. We genuinely care about your success . We build strong partnerships with your team, respecting their time and valuing their experience.  Talk to us about how we can help you accelerate or kick off your human-tech powered journey.
Investor
May 2022
OpenDialog is the multi-agent AI platform transforming how insurers, brokers and MGAs convert, serve and retain customers. Instead of generic chatbots or fragmented automation, OpenDialog deploys specialised AI Agents - each trained on insurance journeys, intent patterns and regulatory expectations - to intervene exactly where digital journeys break. Selma boosts quote-to-bind conversion by reducing drop-off at the most complex moments. Jamie resolves policy questions instantly with compliant, contextual answers that handle customer enquiries without compromise. Rhea re-engages dormant customers, lifting renewals and remarketing outcomes. Together, these agents create an intelligent layer across the entire lifecycle - turning abandoned quotes into bound premiums, policy queries into satisfaction, and missed renewals into predictable revenue. For insurers facing pressure on digital acquisition costs, operational efficiency, and Customer outcomes, OpenDialog delivers measurable impact .. fast. This is AI built for insurance. Not experiments. Not pilots. Real agents delivering real results across the moments that matter most. Discover more at opendialog.ai.
Investor
Jun 2021
HeidiPay is a Swiss fintech enabling merchants, marketplaces and lenders to offer next generation buy-now-pay-later (BNPL) and retail financing solutions to their customers. It operates its B2BC operations under its own brand in Switzerland and provides BNPL-as-a-service solutions internationally for lenders.
Investor
Sep 2020
Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines. Corporate headquarters are located in Dublin, Ireland
Investor
Jun 2020
Fintecture is transforming transfer payments, enabling businesses to free up their turnover in any purchase scenario (online, in-store, remote orders), for immediate or future payment, with 7,000 European customers.
Investor
Dec 2019
Essential Pharma aims to improve patients’ lives by reinvigorating and ensuring the long-term, cost-effective and sustainable supply of Essential medicines. Our vision is to be the leading international specialty pharma company focused on guaranteeing patient access to clinically-differentiated, niche, branded medicines for chronic diseases and acute care – what we call “Essential” medicines. Essential Pharma is made up of innovative and driven people who are passionate about ensuring continued supply of medicines to the patients who are reliant on them. We are committed to living by our values – Collaborative, Responsible, Trustworthy and Dynamic – and pride ourselves on our inclusive culture, where everyone's voice is valued and respected. We have an unwavering dedication to employee growth and believe in fostering an environment where all individuals can thrive. Watch our video to see why employees love working at Essential Pharma, and explore our current vacancies on the Careers Page here: https://essentialpharmagroup.com/careers/
Experience · 21 entries
All (21)
Investments (16)
Board (6)
2025
Investor
Sep 2025
Were an AI research company that builds reliable, interpretable, and steerable AI systems. Our first product is Claude, an AI assistant for tasks at any scale. Our research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.
Investor
Jul 2025
AI agents that actually work in your business. While others struggle to get agents into production, Beam AI delivers reliable automation for Fortune 500 companies and scale-ups. Automate finance, HR, and operations workflows that reduce operational costs and scale your teams impact.
Investor
Mar 2025
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artificial intelligence benefits all of humanity. AI is an extremely powerful tool that must be created with safety and human needs at its core. OpenAI is dedicated to putting that alignment of interests first — ahead of profit. To achieve our mission, we must encompass and value the many different perspectives, voices, and experiences that form the full spectrum of humanity. Our investment in diversity, equity, and inclusion is ongoing, executed through a wide range of initiatives, and championed and supported by leadership. At OpenAI, we believe artificial intelligence has the potential to help people solve immense global challenges, and we want the upside of AI to be widely shared. Join us in shaping the future of technology.
2022
Investor and Board observer
Dec 2022
At Arietta.ai, we empower our customers to achieve brilliant innovation. We are committed to delivering responsible AI-powered solutions that accelerate quality medical decision-making and data insights. Our passion lies in merging cutting-edge artificial intelligence (AI) technologies with a profound understanding of healthcare, driving us to create a healthier world through the convergence of data, innovation, and insight.
Investor
Sep 2022
Founded in 2015, LXO Group is a pharmaceutical company operating a range of products generating annual sales of over 90 million euros and covering more than 80 countries. We are committed to meeting the needs of healthcare professionals and patients for our medicines, medical devices and cosmetics. Our growth is fuelled by the success of our brands, our international expansion and our strategy of external acquisitions. We are supported by a strong workforce, our own sales force and a network of partners and sales representatives who are ready to invest in the development of our products.
Show all 21 entries ↓
Investment activity
2011–2025 · 16 investments
2011120141201522019120202202112022520253
Recent (last 2 years)Earlier